Is it time to consider a role for MRI before prostate biopsy? - Wikidata - awgldk - TriplyDB

Is it time to consider a role for MRI before prostate biopsy?

Is it time to consider a role for MRI before prostate biopsy?

http://www.wikidata.org/entity/Q37427381

about

Clinical application of a 3D ultrasound-guided prostate biopsy system ESUR prostate MR guidelines 2012 Role of multiparametric magnetic resonance imaging in early detection of prostate cancer Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists The role of magnetic resonance imaging in the diagnosis and management of prostate cancer Role of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancer Autonomous real-time interventional scan plane control with a 3-D shape-sensing needle.Acoustic radiation force impulse imaging of human prostates: initial in vivo demonstration.Review of Prostate Imaging Reporting and Data System version 2.Comparison of initial and tertiary centre second opinion reads of multiparametric magnetic resonance imaging of the prostate prior to repeat biopsy A critical comparison of techniques for MRI-targeted biopsy of the prostate.Update on prostate imaging Defining the level of evidence for technology adoption in the localized prostate cancer pathway [Focal prostate cancer therapy: capabilities, limitations and prospects].Clinical applications of multiparametric MRI within the prostate cancer diagnostic pathway MRI-targeted biopsies versus systematic transrectal ultrasound guided biopsies for the diagnosis of localized prostate cancer in biopsy naïve men.PROMIS--Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer.Targeted prostate biopsy and MR-guided therapy for prostate cancer.Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer Value of T1/T2-weighted magnetic resonance imaging registration to reduce the postbiopsy hemorrhage effect for prostate cancer localization Standardized Reporting of Prostate MRI: Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and Version 2 The University College London/Medical Research Council/National Institute of Health Research-Health Technology Assessment PROMIS Trial: An Update.Investigating the ability of multiparametric MRI to exclude significant prostate cancer prior to transperineal biopsy.Targeted transperineal biopsy of the prostate has limited additional benefit over background cores for larger MRI-identified tumors.Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer Increased rate of positive biopsies using a combination of MR-Tomography, spectroscopy and diffusion-weighted magnetic resonance imaging prior to prostate biopsies in patients with persistent elevated prostate-specific antigen values: A retrospectiv Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer Comparison of T2(*) mapping with diffusion-weighted imaging in the characterization of low-grade vs intermediate-grade and high-grade prostate cancer.Prostate cancer screening and the management of clinically localized disease.Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies.Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard.Is focal therapy the future for prostate cancer?Evolution of precise and multimodal MRI and TRUS in detection and management of early prostate cancer.A decade in prostate cancer: from NMR to metabolomics.Prostate cancer detection after a negative prostate biopsy: lessons learnt in the Cleveland Clinic experience.Value of multiparametric MRI in the work-up of prostate cancer.Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer.The emerging role of diffusion-weighted MRI in prostate cancer management.A biomedical engineering approach to mitigate the errors of prostate biopsy.Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway?

P2860

Q24608010-D82FAC7A-F7A5-4C6B-9962-23583D4CD668 Q24620926-E345F0D5-6112-4F31-AD78-31DFB4B591C5 Q26768765-6EE98D03-1610-4EBF-B871-0747E6B9D6D6 Q26801576-71A291C2-96BE-47B8-A1CF-A4D9210313B1 Q26849794-09F43312-C3B2-4027-951D-E02BCC73D5C2 Q26998938-E1A08E77-B3CA-435F-80F8-6A23BC84FD2F Q27316450-B1DD3644-2B9A-4C52-9420-27A62F3CDD93 Q30459679-22C63949-9525-4996-A3E4-6051F189DC06 Q31131775-9FF2F835-786D-4ED1-8DC8-3A23184170AD Q33611513-E1CB30DA-209B-43EE-89E3-47AB082E6655 Q33890165-95943ECA-7762-4249-B203-FE00F303FA7C Q33908505-710359E9-DA21-45E5-A90E-BC8BABDB71E7 Q34061419-30D394C9-7B3D-4F00-B958-818C721E2A3B Q34448994-FA468B9C-329F-4960-8CDF-42F998DFDE8A Q34761435-709204C6-8E85-44CD-9D40-F16788E0F354 Q35068260-66352813-C541-443F-9566-C98D93BAE363 Q35700730-A90D10BB-F68A-4F2D-AF15-FEFE9B134666 Q35933229-3F237232-F667-4F89-869E-C069C326901C Q35985579-32AE3EAA-8CF4-411D-B829-3BC4C01E29C8 Q36106249-70F469FF-1116-4AAE-AA7F-34902A896745 Q36140880-B1A62E76-66D0-40D0-B292-B7F338569DF8 Q36411193-8737E178-0FCD-4E20-AED1-3B7527CF2A6C Q36449937-A91875BD-95F6-4147-B9E1-582F7B548850 Q36706373-FB7F52C4-71BE-4FF7-B1DE-2E26177C3E72 Q36928846-27343320-AF19-4B99-A2E0-226F8BB99C0E Q36938017-2A57C96D-57E3-4BEA-8E0D-DEED248CBF17 Q37254919-24E78A98-7D8A-4F17-81BE-AA2B26B2D612 Q37600905-7F11B5AA-F27F-475D-94EC-1D212E1294ED Q37609671-1A4FD7C1-6F5D-49C6-8297-60110E1C3877 Q37610819-F69C83C3-CEF4-401B-8404-09C1E5BCC0A2 Q37638550-0578A15A-0FC0-45E3-961C-E72D72C17E12 Q37690305-6ED1A198-C009-4692-BC2A-9FE3F8F1CAFF Q37768170-2FBC6233-B10C-4A06-B944-FCD04EB0DC19 Q37876681-4EA4AF99-36C4-4D78-B9A8-A30AE564E858 Q37892629-DC8FAB39-6B86-4341-94C8-8DE5A60002D4 Q37964563-33DADF4B-C448-4F47-A178-4E05962286DF Q37975227-15E5D8A3-4EF3-4CA0-854C-DDF1C69411DD Q37976257-17645698-B74D-46D4-B65F-E719F2A0AD02 Q37981828-93C6CDB6-02F6-4471-8227-03C646D40F43 Q38008282-5936FF7F-5AD5-4778-946A-18429107CB4D

P2860

Is it time to consider a role for MRI before prostate biopsy?

http://www.wikidata.org/entity/Q37427381

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Is it time to consider a role for MRI before prostate biopsy?

@en

Is it time to consider a role for MRI before prostate biopsy?

@nl

type

label

Is it time to consider a role for MRI before prostate biopsy?

@en

Is it time to consider a role for MRI before prostate biopsy?

@nl

prefLabel

Is it time to consider a role for MRI before prostate biopsy?

@en

Is it time to consider a role for MRI before prostate biopsy?

@nl

P1433

Q37427381-994E8F44-C187-42FF-9032-E8C2B56671B8

P1476

Q37427381-D7E5F6DA-EFCA-4E88-B3E6-1D7934753B45

P2093

Q37427381-2EF1FB81-37B1-4760-8690-19D7A68FC2A2

Q37427381-37A35755-2EBA-438A-900D-C881E50C0E04

Q37427381-59BF9AE3-2E7C-47C8-8B7B-261BCAE390EC

Q37427381-6846BF1C-F4ED-489A-9E3A-645524C1089B

Q37427381-7B870B4C-3637-4C28-8710-E2D365A3CD54

Q37427381-B03F8649-3451-4DDD-9A40-20872EBE057E

P2860

Q37427381-004855FD-ABDD-40D6-AF5C-9A02C2E11A33

Q37427381-068C5F1A-33E4-47D4-9314-1AB359C12FEF

Q37427381-0AB2CD83-767E-40E2-A182-C1C677BFA192

Q37427381-32D10FBD-54E1-4A74-B933-FC7092A3D78A

Q37427381-33BFCA60-67E1-4D5E-B432-82125C81A0A8

Q37427381-6658DAA1-670F-405D-A215-E4DFA3B23295

Q37427381-7B6E2B22-1541-4053-96E6-E5E213B37700

Q37427381-AA868FF6-67D0-4DC8-8803-33794C741963

Q37427381-E80A9255-AA11-43F6-AF9C-FA63165E10CB

P2888

Q37427381-F8826C5C-5456-4BB9-8C52-6C42E05631A3

P304

Q37427381-4167F4DB-1A8E-4104-9539-F637FA4944FC

P31

Q37427381-F49CFB3C-D946-4F4F-A262-9D7276347BD9

P356

Q37427381-FA41A901-037C-48AE-BC9F-8AE931221E05

P407

Q37427381-F211DC05-F1E5-46EF-BFAB-9B9F965869BA

P433

Q37427381-0907FCAD-3F88-4CF0-AA9D-4655F5EE956D

P478

Q37427381-9855481B-0AC2-47E8-B6A2-A13E783471AC

P50

Q37427381-24F77A40-DC4D-49C9-B6E9-0161975F5D38

P577

Q37427381-E622F823-0864-40AE-B55F-0B0CC61AB28C

P5875

Q37427381-771487BA-698F-479B-9A2D-340653740A01

P6179

Q37427381-1BD5A492-2334-4C6C-999B-71E66E960FD0

P698

Q37427381-FF837F4B-F9E6-437B-9699-37C6F7F49888

P921

Q37427381-7EB82253-BF13-404C-A6C2-4182362D130A

P356

NRCLINONC.2009.18

P1433

Nature Reviews Clinical Oncology

P1476

Is it time to consider a role for MRI before prostate biopsy?

@en

P2093

Alex Freeman

http://www.w3.org/2001/XMLSchema#string

Alex Kirkham

http://www.w3.org/2001/XMLSchema#string

Clare Allen

http://www.w3.org/2001/XMLSchema#string

Hashim U Ahmed

http://www.w3.org/2001/XMLSchema#string

Manit Arya

http://www.w3.org/2001/XMLSchema#string

Rowland Illing

http://www.w3.org/2001/XMLSchema#string

P2860

The role of endorectal coil MRI in patient selection and treatment planning for prostate seed implants.

Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis.

Impact of variations in prostatic apex shape on early recovery of urinary continence after radical retropubic prostatectomy.

Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images.

Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy.

Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate.

Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI.

Is it time to change the standard of care from CT to MRI for defining the apex of the prostate to accomplish potency-sparing radiotherapy?

Towards integrating functional imaging in the treatment of prostate cancer with radiation: the registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning.

P2888

nrclinonc.2009.18

P304

197-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCLINONC.2009.18

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24245504

http://www.w3.org/2001/XMLSchema#string

P6179

1015168164

http://www.w3.org/2001/XMLSchema#string

P698

19333226

http://www.w3.org/2001/XMLSchema#string

P921